TrialNeurology(R) neuroimmunology & neuroinflammation2024

Pharmacokinetics and Pharmacodynamics of Natalizumab 6-Week Dosing vs Continued 4-Week Dosing for Relapsing-Remitting Multiple Sclerosis.

John F Foley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.